Iesato A, Li S, Sadow PM, Abbasian M, et al. The tyrosine kinase inhibitor lenvatinib inhibits anaplastic thyroid carcinoma growth by targeting pericytes in the tumor microenvironment. Thyroid 2023 May 12. doi: 10.1089/thy.2022.0597.
PMID: 37171127